nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0723	0.229	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—RYR2—dilated cardiomyopathy	0.0472	0.15	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—PLN—dilated cardiomyopathy	0.0459	0.146	CbGpPWpGaD
Lubiprostone—Lethargy—Spironolactone—dilated cardiomyopathy	0.0226	0.035	CcSEcCtD
Lubiprostone—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0199	0.0309	CcSEcCtD
Lubiprostone—Gastritis—Spironolactone—dilated cardiomyopathy	0.0196	0.0303	CcSEcCtD
Lubiprostone—CLCN2—heart—dilated cardiomyopathy	0.0173	0.431	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0168	0.0532	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0164	0.0521	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.016	0.0507	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.016	0.0507	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0148	0.0471	CbGpPWpGaD
Lubiprostone—CLCN2—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.0143	0.0453	CbGpPWpGaD
Lubiprostone—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.014	0.0218	CcSEcCtD
Lubiprostone—Swelling—Furosemide—dilated cardiomyopathy	0.0136	0.0211	CcSEcCtD
Lubiprostone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0128	0.0198	CcSEcCtD
Lubiprostone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0124	0.0192	CcSEcCtD
Lubiprostone—Lethargy—Furosemide—dilated cardiomyopathy	0.0123	0.019	CcSEcCtD
Lubiprostone—Malaise—Spironolactone—dilated cardiomyopathy	0.012	0.0186	CcSEcCtD
Lubiprostone—Discomfort—Spironolactone—dilated cardiomyopathy	0.0112	0.0174	CcSEcCtD
Lubiprostone—Cramp muscle—Furosemide—dilated cardiomyopathy	0.0108	0.0168	CcSEcCtD
Lubiprostone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0105	0.0162	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0104	0.0329	CbGpPWpGaD
Lubiprostone—CBR1—myocardium—dilated cardiomyopathy	0.00993	0.248	CbGeAlD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00975	0.031	CbGpPWpGaD
Lubiprostone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.0096	0.0149	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00938	0.0145	CcSEcCtD
Lubiprostone—CLCN2—Ion channel transport—RAF1—dilated cardiomyopathy	0.0093	0.0295	CbGpPWpGaD
Lubiprostone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00895	0.0139	CcSEcCtD
Lubiprostone—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00813	0.0126	CcSEcCtD
Lubiprostone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.008	0.0124	CcSEcCtD
Lubiprostone—Gastritis—Lisinopril—dilated cardiomyopathy	0.00799	0.0124	CcSEcCtD
Lubiprostone—Influenza—Lisinopril—dilated cardiomyopathy	0.0078	0.0121	CcSEcCtD
Lubiprostone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00743	0.0115	CcSEcCtD
Lubiprostone—Erythema—Furosemide—dilated cardiomyopathy	0.00724	0.0112	CcSEcCtD
Lubiprostone—Malnutrition—Furosemide—dilated cardiomyopathy	0.00724	0.0112	CcSEcCtD
Lubiprostone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00718	0.0111	CcSEcCtD
Lubiprostone—Flatulence—Furosemide—dilated cardiomyopathy	0.00714	0.0111	CcSEcCtD
Lubiprostone—Weight increased—Lisinopril—dilated cardiomyopathy	0.0071	0.011	CcSEcCtD
Lubiprostone—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00709	0.011	CcSEcCtD
Lubiprostone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00696	0.0108	CcSEcCtD
Lubiprostone—CBR1—heart—dilated cardiomyopathy	0.00693	0.173	CbGeAlD
Lubiprostone—Vomiting—Spironolactone—dilated cardiomyopathy	0.00691	0.0107	CcSEcCtD
Lubiprostone—Rash—Spironolactone—dilated cardiomyopathy	0.00685	0.0106	CcSEcCtD
Lubiprostone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00684	0.0106	CcSEcCtD
Lubiprostone—Headache—Spironolactone—dilated cardiomyopathy	0.00681	0.0106	CcSEcCtD
Lubiprostone—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00676	0.0105	CcSEcCtD
Lubiprostone—Nausea—Spironolactone—dilated cardiomyopathy	0.00645	0.01	CcSEcCtD
Lubiprostone—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00615	0.00954	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00612	0.00949	CcSEcCtD
Lubiprostone—Dry mouth—Furosemide—dilated cardiomyopathy	0.00603	0.00935	CcSEcCtD
Lubiprostone—CBR1—cardiac atrium—dilated cardiomyopathy	0.00593	0.148	CbGeAlD
Lubiprostone—Shock—Furosemide—dilated cardiomyopathy	0.00582	0.00902	CcSEcCtD
Lubiprostone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.0058	0.00899	CcSEcCtD
Lubiprostone—Skin disorder—Furosemide—dilated cardiomyopathy	0.00574	0.0089	CcSEcCtD
Lubiprostone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00571	0.00886	CcSEcCtD
Lubiprostone—Anorexia—Furosemide—dilated cardiomyopathy	0.00563	0.00874	CcSEcCtD
Lubiprostone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00563	0.00872	CcSEcCtD
Lubiprostone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00547	0.00848	CcSEcCtD
Lubiprostone—Erythema—Lisinopril—dilated cardiomyopathy	0.00543	0.00843	CcSEcCtD
Lubiprostone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00543	0.00843	CcSEcCtD
Lubiprostone—Flatulence—Lisinopril—dilated cardiomyopathy	0.00535	0.0083	CcSEcCtD
Lubiprostone—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00532	0.00825	CcSEcCtD
Lubiprostone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00522	0.0081	CcSEcCtD
Lubiprostone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00514	0.00797	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0051	0.00791	CcSEcCtD
Lubiprostone—Fatigue—Furosemide—dilated cardiomyopathy	0.0051	0.0079	CcSEcCtD
Lubiprostone—Tremor—Lisinopril—dilated cardiomyopathy	0.00509	0.00789	CcSEcCtD
Lubiprostone—Constipation—Furosemide—dilated cardiomyopathy	0.00505	0.00784	CcSEcCtD
Lubiprostone—Pain—Furosemide—dilated cardiomyopathy	0.00505	0.00784	CcSEcCtD
Lubiprostone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00504	0.00782	CcSEcCtD
Lubiprostone—Malaise—Lisinopril—dilated cardiomyopathy	0.0049	0.0076	CcSEcCtD
Lubiprostone—Syncope—Lisinopril—dilated cardiomyopathy	0.00487	0.00756	CcSEcCtD
Lubiprostone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00487	0.00755	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00483	0.00749	CcSEcCtD
Lubiprostone—Palpitations—Lisinopril—dilated cardiomyopathy	0.0048	0.00745	CcSEcCtD
Lubiprostone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00478	0.00741	CcSEcCtD
Lubiprostone—Cough—Lisinopril—dilated cardiomyopathy	0.00474	0.00735	CcSEcCtD
Lubiprostone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00467	0.00725	CcSEcCtD
Lubiprostone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00463	0.00717	CcSEcCtD
Lubiprostone—Chest pain—Lisinopril—dilated cardiomyopathy	0.00463	0.00717	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00462	0.0147	CbGpPWpGaD
Lubiprostone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00461	0.00715	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00459	0.00712	CcSEcCtD
Lubiprostone—Discomfort—Lisinopril—dilated cardiomyopathy	0.00457	0.00709	CcSEcCtD
Lubiprostone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00452	0.00702	CcSEcCtD
Lubiprostone—Oedema—Lisinopril—dilated cardiomyopathy	0.00444	0.00688	CcSEcCtD
Lubiprostone—Shock—Lisinopril—dilated cardiomyopathy	0.00436	0.00677	CcSEcCtD
Lubiprostone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00436	0.00675	CcSEcCtD
Lubiprostone—CBR1—Metabolism—TAZ—dilated cardiomyopathy	0.00434	0.0138	CbGpPWpGaD
Lubiprostone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00433	0.00671	CcSEcCtD
Lubiprostone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00431	0.00668	CcSEcCtD
Lubiprostone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00429	0.00665	CcSEcCtD
Lubiprostone—Asthenia—Furosemide—dilated cardiomyopathy	0.00424	0.00658	CcSEcCtD
Lubiprostone—Anorexia—Lisinopril—dilated cardiomyopathy	0.00423	0.00655	CcSEcCtD
Lubiprostone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00404	0.00627	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00404	0.00627	CcSEcCtD
Lubiprostone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00395	0.00613	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SDHA—dilated cardiomyopathy	0.00393	0.0125	CbGpPWpGaD
Lubiprostone—Dizziness—Furosemide—dilated cardiomyopathy	0.00391	0.00606	CcSEcCtD
Lubiprostone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.0039	0.00605	CcSEcCtD
Lubiprostone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00386	0.00598	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00383	0.00594	CcSEcCtD
Lubiprostone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00382	0.00593	CcSEcCtD
Lubiprostone—Pain—Lisinopril—dilated cardiomyopathy	0.00379	0.00588	CcSEcCtD
Lubiprostone—Constipation—Lisinopril—dilated cardiomyopathy	0.00379	0.00588	CcSEcCtD
Lubiprostone—Vomiting—Furosemide—dilated cardiomyopathy	0.00376	0.00583	CcSEcCtD
Lubiprostone—Rash—Furosemide—dilated cardiomyopathy	0.00373	0.00578	CcSEcCtD
Lubiprostone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00372	0.00577	CcSEcCtD
Lubiprostone—Headache—Furosemide—dilated cardiomyopathy	0.0037	0.00574	CcSEcCtD
Lubiprostone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00365	0.00567	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00363	0.00562	CcSEcCtD
Lubiprostone—Nausea—Furosemide—dilated cardiomyopathy	0.00351	0.00544	CcSEcCtD
Lubiprostone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00351	0.00544	CcSEcCtD
Lubiprostone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00327	0.00507	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00324	0.0103	CbGpPWpGaD
Lubiprostone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00318	0.00493	CcSEcCtD
Lubiprostone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00303	0.00471	CcSEcCtD
Lubiprostone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00293	0.00455	CcSEcCtD
Lubiprostone—Vomiting—Lisinopril—dilated cardiomyopathy	0.00282	0.00437	CcSEcCtD
Lubiprostone—Rash—Lisinopril—dilated cardiomyopathy	0.0028	0.00434	CcSEcCtD
Lubiprostone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00279	0.00433	CcSEcCtD
Lubiprostone—Headache—Lisinopril—dilated cardiomyopathy	0.00278	0.00431	CcSEcCtD
Lubiprostone—Nausea—Lisinopril—dilated cardiomyopathy	0.00263	0.00408	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.0024	0.00761	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00233	0.00741	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.0021	0.00667	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPX1—dilated cardiomyopathy	0.00107	0.00339	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CD36—dilated cardiomyopathy	0.00104	0.0033	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AGT—dilated cardiomyopathy	0.000936	0.00297	CbGpPWpGaD
